Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions highlight promising results from new trials, such as Eyestem’s phase 1 trial showing positive outcomes, and reviews of generating iPSC-based therapies for dry AMD, using phrases like 'revolutionary' and 'hopeful developments' which indicate a generally optimistic tone that underscores the potential impact of these advancements.
Most discussions reflect optimistic support for the advancements and potential of stem cell therapies for AMD, indicating agreement with the publication's significance.
Comments show moderate curiosity, with mentions of trial results and new protocols pointing to a general interest in the scientific progress.
Participants discuss specific developments like the Eyestem trial results and protocol reviews, implying some deep engagement.
The emphasis on positive trial outcomes and the development of new therapeutic approaches suggests recognition of a meaningful impact on future AMD treatments.
A review that discusses protocols for the generation of induced pluripotent #StemCell and recent developments regarding therapies for dry AMD. https://t.co/ke7fH6vghX
Eyestem releases positive results from phase 1 trial in patients with geographic atrophy Eyecyte-RPE is a suspension of human induced Pluripotent Stem Cells derived retinal pigment epithelial cells. www.ophthalmologytimes.com/view/eyestem...
Human-induced pluripotent stem cells offer a promising approach for treating AMD by generating retinal pigment epithelium cells, crucial for restoring retinal function. This review discusses recent progress in using…
Human-induced pluripotent stem cells offer a promising approach for treating age-related macular degeneration by generating retinal pigment epithelium cells. This review covers production methods and recent progress in…
Human-induced pluripotent stem cells offer promising approaches for treating AMD by generating retinal pigment epithelium cells, crucial for restoring retinal function. This review discusses recent progress in using…
Human-induced pluripotent stem cells offer a promising approach for treating age-related macular degeneration by generating retinal pigment epithelium cells, crucial for restoring retinal function.
Human-induced pluripotent stem cells offer a promising new approach for treating AMD by generating retinal pigment epithelium cells, crucial for restoring retinal function and vision.
Eyestem releases positive results from phase 1 trial in patients with geographic atrophy Eyecyte-RPE is a suspension of human induced Pluripotent Stem Cells derived retinal pigment epithelial cells. www.ophthalmologytimes.com/view/eyestem...
A review that discusses protocols for the generation of induced pluripotent #StemCell and recent developments regarding therapies for dry AMD. https://t.co/ke7fH6vghX